VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2020 | The role of isatuximab in the management of MM

Mohamad Mohty, MD, PhD, Saint-Antoine Hospital, Paris, France, discusses the role of isatuximab in the management of multiple myeloma (MM). Particularly, Prof. Mohty mentions the IKEMA study (NCT03275285), investigating isatuximab plus carfilzomib and dexamethasone vs. carfilzomib and dexamethasone in relapsed/refractory MM. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter